WASHINGTON, DC—Black non-Hispanics and Hispanics often receive more equitable care under Tricare than in other parts of the US healthcare system, but disparities persist in how they view their health status, according to study published in the July issue of the Journal of the National Medical Association. Full Article

WASHINGTON, DC—An investigational HIV vaccine has been shown to be safe and moderately effective in protecting people from the virus, officials announced at the end of September. Full Article

WASHINGTON, DC—Bob Filner (D-CA), Chairman of the House Committee on Veterans’ Affairs, announced that the House of Representatives approved a critical funding increase for a paralympic program for veterans and members of the Armed Services. Full Article

WASHINGTON, DC—When servicemembers are on active deployment, they are not the only ones who may be affected by their departure; their children may also feel strained. Full Article

BETHESDA, MD—Mood disorders remain some of the most debilitating diseases afflicting the nation. Major depression is the leading cause of disability in the world, topping even heart disease. Bipolar disorder ranks at number 8. Full Article

WASHINGTON, DC—some veterans advocates are accusing the Department of Veterans Affairs formulary and its administrative system of not being properly transparent, and of making it too difficult for VA physicians to prescribe non-formulary medications when necessary. Full Article

washington, dc—The Department of Veterans Affairs should direct more of its time and resources to explaining burial benefits to veterans, legislators told VA officials last month. Full Article

WASHINGTON, DC—Last month, CDC announced that it has awarded a total of $22 million to 26 states and tribal organizations in order to provide colorectal cancer screening services for low–income people aged 50–64 years, who are underinsured or uninsured. Full Article

WASHINGTON, DC—The Department of Veterans Affairs health care system provides both benefits and obstacles for anyone looking to conduct pharmaceutical trials in their patient population. Full Article

WASHINGTON, DC—To screen or not to screen? That is the question that many male patients must ask themselves when it comes to prostate cancer. Full Article